- Category
- Micro (2020-21)
- Udyam number
- UDYAM-GJ-01-0019701

Lecorps Pharma LLP
About Lecorps Pharma LLP
Data last updated:
Lecorps Pharma LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the chemicals and chemical products segment of the chemicals sector. It was incorporated on 13 November 2019 and has been in existence for over 7 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAR-0172. Its GSTIN is 24AAIFL6664P1ZM (Gujarat). The LLP holds 2 GST registrations, all of them active.
The LLP has a total obligation of contribution of βΉ1.25 Lakh. It is led by designated partners Ritesh Joshi and Vineet Sharma.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
Lecorps Pharma LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0019701).
Company details
Recognitions & Rankings of Lecorps Pharma
Contact details
Lecorps Pharma LLP's registered office is in Ahmedabad, Gujarat.
- Registered AddressBlock B Office No 211 Dev Auram, Anandnagar Char Rasta Prahladnagar Road Prahladnagar, Ahmedabad, Gujarat, India β 380015
- IndustryChemicals, Chemicals and Chemical Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Lecorps Pharma LLP
FY 2025 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | |||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | |||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Lecorps Pharma LLP, buy the company report.
Designated partners of Lecorps Pharma LLP
Lecorps Pharma has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritesh Joshi | Designated Partner | 13 Nov 2019 | 7 Years 0 Months | Current |
| Vineet Sharma Also directs: Lecorps Healthcare LLP, Lecorps Infra LLP | Designated Partner | 06 Apr 2023 | 3 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Lecorps Pharma LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lecorps Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lecorps Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAIFL6664P1ZM | Gujarat | Active | 22 Feb 2021 |
| 08AAIFL6664P1ZG | Rajasthan | Active | 28 Jun 2023 |
To see the full GST registrations and return filing status of Lecorps Pharma LLP, buy the company report.
Recent activity
Lecorps Pharma LLP has 2 designated partner changes on record since 2019: 2 appointments. The latest: Vineet Sharma was appointed as Designated Partner on 06 Apr 2023.
Frequently asked questions
Lecorps Pharma is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in chemicals and chemical products, within the chemicals industry. It was incorporated on 13 November 2019 (7+ years old) and is registered under LLPIN AAR-0172.
Lecorps Pharma has 2 current designated partners:
- Ritesh Joshi - Designated Partner
- Vineet Sharma - Designated Partner
The latest financial statements of Lecorps Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Lecorps Pharma is 24AAIFL6664P1ZM, registered in Gujarat. The LLP has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 08AAIFL6664P1ZG (Rajasthan).
The LLPIN (Limited Liability Partnership Identification Number) of Lecorps Pharma is AAR-0172. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Lecorps Pharma was incorporated on 13 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Vineet Sharma was appointed as Designated Partner on 06 Apr 2023. Ritesh Joshi was appointed as Designated Partner on 13 Nov 2019.
Yes, Lecorps Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0019701).
The registered office of Lecorps Pharma is at Block B Office No 211 Dev Auram, Anandnagar Char Rasta Prahladnagar Road Prahladnagar, Ahmedabad, Gujarat, India β 380015.
Lecorps Pharma operates in the chemicals industry, in the chemicals and chemical products segment.

